Home › COPD › South Carolina › Charleston
COPD clinical trials in Charleston, SC
4 studies for COPD are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
RecruitingPhase 3
- Lowcountry Lung & Critical Care, PA ( Site 4413), Charleston
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecruitingPhase 3
- GC2501 Study Site 101, Charleston
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, Charleston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RecruitingObservational study
- Medical University of South Carolina (MUSC), Charleston
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA26 studies
- Miami, FL20 studies
- Houston, TX18 studies
- Birmingham, AL17 studies
- Baltimore, MD16 studies
- Boston, MA15 studies
- Orlando, FL15 studies
- Chicago, IL15 studies
- Dallas, TX13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Winston-Salem, NC11 studies
Other studies in Charleston
- Stroke19 studies
- Depression18 studies
- Post-Traumatic Stress Disorder16 studies
- Head and Neck Squamous Cell Carcinoma16 studies
- Heart Failure16 studies
- Non-Small Cell Lung Cancer16 studies
- Prostate Cancer16 studies
- Cardiovascular Disease16 studies
- Cancer (all types)14 studies
- Parkinson's Disease13 studies
- Breast Cancer12 studies
- Lung Cancer12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.